SMYD3 and diffuse large B-cell lymphoma: Together, these results suggested that SMYD3 played an important role in promoting DLBCL cell proliferation in vitro and in vivo and that SMYD3 induced doxorubicin and vincristine resistance in DLBCL cells in vitro.